From February 7, 2022 to March 31, 2022, the company has repurchased 750,342 shares, representing 0.05% for CNY 7.44 million. With this, the company has completed the repurchase of 750,342 shares, representing 0.05% for CNY 7.44 million under the buyback announced on February 8, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.1 CNY | -0.39% | -1.37% | -1.17% |
04-25 | Anhui Anke Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-28 | Anhui Anke Biotechnology Co., Ltd. Proposes Final Dividend for 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.17% | 2.33B | |
-1.62% | 89.22B | |
+2.24% | 40.49B | |
-12.97% | 32.79B | |
+63.62% | 26.23B | |
-20.71% | 14.52B | |
-7.31% | 13.09B | |
-12.64% | 11.5B | |
-42.60% | 11.6B | |
+5.62% | 8.82B |
- Stock Market
- Equities
- 300009 Stock
- News Anhui Anke Biotechnology (Group) Co., Ltd.
- Tranche Update on Anhui Anke Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 8, 2022.